StockData
Airsculpt Technologies, Inc. logo

Airsculpt Technologies, Inc. (AIRS) stock

AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3084% below fair value
$0.74+0.04 (+5.53%)

Close on Nov 17, 2026Market cap $53.26MP/E –Yield –

Airsculpt Technologies ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Airsculpt Technologies's ebitda for the twelve months ending Jun 30, 2026 was -$333.00K, down 107.8% year over year. For fiscal 2025 it was $1.22M, down 88.2% from the year before. The highest annual figure on record is $22.37M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.22M-88.2%
FY2024Dec 31, 2024$10.31M-48.4%
FY2023Dec 31, 2023$19.98M+468.1%
FY2022Dec 31, 2022$3.52M-84.3%
FY2021Dec 31, 2021$22.37M+42.7%
FY2020Dec 31, 2020$15.67M+178.7%
FY2019Dec 31, 2019$5.62M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.91M-27.8%
Q1 FY2026Mar 31, 2026$1.22M-26.3%
Q4 FY2025Dec 31, 2025$2.07M–
Q3 FY2025Sep 30, 2025-$6.53M–
Q2 FY2025Jun 30, 2025$4.03M–
Q1 FY2025Mar 31, 2025$1.65M-88.0%
Q4 FY2024Dec 31, 2024-$703.00K-115.9%
Q3 FY2024Sep 30, 2024-$713.00K-119.9%
Q2 FY2024Jun 30, 2024-$2.10M-126.6%
Q1 FY2024Mar 31, 2024$13.82M+237.2%
Q4 FY2023Dec 31, 2023$4.42M–
Q3 FY2023Sep 30, 2023$3.58M+479.0%
Q2 FY2023Jun 30, 2023$7.88M+32.9%
Q1 FY2023Mar 31, 2023$4.10M+473.1%
Q4 FY2022Dec 31, 2022-$3.74M–
Q3 FY2022Sep 30, 2022$619.00K-94.5%
Q2 FY2022Jun 30, 2022$5.93M-53.5%
Q1 FY2022Mar 31, 2022$715.00K-91.8%
Q4 FY2021Dec 31, 2021-$10.32M–
Q3 FY2021Sep 30, 2021$11.26M–
Q2 FY2021Jun 30, 2021$12.73M–
Q1 FY2021Mar 31, 2021$8.70M–

More Airsculpt Technologies figures

See a number that looks wrong?